Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
MP Biomedicals™ Mycoplasma Removal Agent (MRA)
Mycoplasma Removal Agent (MRA) is a derivative of the quinoline family of antibiotics and eliminates mycoplasma contamination in cell cultures by inhibiting mycoplasma DNA gyrase.
Supplier: MP Biomedicals™ 093050044
Description
- Derivative of the quinoline family of antibiotics and eliminates mycoplasma infection by inhibiting mycoplasma DNA gyrase
- Supplied as a ready-to-use solution
- Cited by the European Collection of Animal Cell Cultures (Porton Down, U.K.) as being superior to all other current products for the eradication of mycoplasma
- Cell toxicity is low following treatment at the recommended concentration of 0.5 μg/mL
- Eliminates multiple mycoplasma species within one week using the lowest dosage
- Prevents recontamination of the culture at 0.1 μg/mL
- Maintains cell viability
- Compatible with most mammalian cell lines
- Sterility and low cytotoxicity
Specifications
| Store at Room Temperature (15 to 30°C). Protect from light. | |
| Clear, light yellow solution | |
| Sterile | |
| 5 mL |
| 50 µg/mL | |
| Mycoplasma Removal | |
| Mycoplasma elimination |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Product Content Correction